ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,901Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 96

$1.04M Total Retail Price of All Prescriptions

Rank: 8 out of 96

767 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 767 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

5% of this provider’s 767 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 12,701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 807 756 1 1
LEVOTHYROXINE SODIUM 663 585 2 3
OMEPRAZOLE 401 367 3 5
FUROSEMIDE 380 359 4 4
WARFARIN SODIUM 379 372 5 6
METOPROLOL SUCCINATE 281 254 6 9
METOPROLOL TARTRATE 260 247 7 7
AMLODIPINE BESYLATE 255 252 8 2
HYDROCHLOROTHIAZIDE 199 192 9 16
LISINOPRIL 197 179 10 10
ATORVASTATIN CALCIUM 195 179 11 12
FAMOTIDINE 185 166 12 21
GABAPENTIN 184 176 13 20
METFORMIN HCL 180 169 14 13
ZOLPIDEM TARTRATE 161 149 15 18
TRAMADOL HCL 157 129 16 35
LOSARTAN POTASSIUM 155 151 17 23
IPRATROPIUM-ALBUTEROL 154 138 18 57
LIDODERM 138 135 19 45
POTASSIUM CHLORIDE 136 136 20 19
LOSARTAN-HYDROCHLOROTHIAZIDE 134 127 21 88
ATENOLOL 125 124 22 30
AMOX TR-POTASSIUM CLAVULANATE 125 108 22 135
OXYCODONE-ACETAMINOPHEN 121 105 S2 24 26
DONEPEZIL HCL 116 116 25 8
DIOVAN 112 110 26 17
CRESTOR 110 97 27 39
CITALOPRAM HBR 110 102 27 25
ENALAPRIL MALEATE 108 101 29 28
MIRTAZAPINE 106 98 30 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 105 31 98
BYSTOLIC 104 97 32 56
CIPROFLOXACIN HCL 104 92 32 97
RAMIPRIL 101 78 34 69
PREDNISONE 99 97 35 58
LANTUS SOLOSTAR 99 91 35 87
PRAVASTATIN SODIUM 98 94 37 33
DIOVAN HCT 94 89 38 64
AZITHROMYCIN 94 87 38 54
PROAIR HFA 92 75 40 72
CARVEDILOL 91 87 41 22
NAMENDA 88 88 42 11
CLOPIDOGREL 87 78 43 27
SERTRALINE HCL 87 84 43 15
CYMBALTA 85 68 45 51
ISOSORBIDE MONONITRATE ER 84 82 46 60
SPIRONOLACTONE 82 82 47 70
GLIMEPIRIDE 81 78 48 43
ALENDRONATE SODIUM 80 77 49 36
ADVAIR DISKUS 72 69 50 46
RISPERIDONE 72 67 50 31
DIGOXIN 71 67 52 34
FENTANYL 68 46 S2 53 50
TRIAMTERENE-HCTZ 67 67 54 148
METFORMIN HCL ER 64 60 55 111
PANTOPRAZOLE SODIUM 63 62 56 44
NEXIUM 63 45 56 40
LEVOFLOXACIN 62 55 58 59
ALLOPURINOL 62 62 58 82
ESCITALOPRAM OXALATE 60 42 60 24
BISOPROLOL FUMARATE 60 60 60 192
PAROXETINE HCL 60 60 60 66
TAMSULOSIN HCL 59 56 63 29
HYDROCODONE-ACETAMINOPHEN 58 46 S3 64 52
FLUTICASONE PROPIONATE 58 51 64 55
PLAVIX 56 50 66 42
GLIPIZIDE XL 55 51 67 161
SYNTHROID 55 48 67 99
NIFEDIPINE ER 54 53 69 118
LANTUS 53 42 70 68
PEN NEEDLE 52 49 71 164
TRICOR 52 44 71 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.